fbpx
February 27, 2024

Patent Certifications and Suitability Petitions

FDA aspires to continually improve its pre-ANDA (abbreviated new drug application) interactions with applicants. To facilitate these interactions and keep stakeholders as informed as possible, the […]
February 27, 2024

FDA Roundup: February 27, 2024

For Immediate Release: February 27, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, […]
February 27, 2024

Spotlight on CDER Science

Safety Outcomes When “Switching” Between Biosimilars and Reference Products Biological products (biologics) play an important role in clinical care, providing safe and effective treatments for many […]
February 27, 2024

Delsam Pharma LLC – 657340 – 02/13/2024

Delivery Method: Via Electronic Mail – Delivery and Read Receipt Requested Product: Drugs Recipient: Recipient Name Mr. Kuppusamy Arumugam Recipient Title President / Owner Delsam Pharma […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0